Invention Grant
- Patent Title: Method of treatment for glioblastoma by administering a VEGF antagonist
-
Application No.: US15346164Application Date: 2016-11-08
-
Publication No.: US10208355B2Publication Date: 2019-02-19
- Inventor: Carlos Bais , Richard Bourgon , Thomas Sandmann
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Clark & Elbing LLP
- Agent Karen L. Elbing
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K45/06 ; C07K16/22 ; A61K39/395 ; A61K31/4188 ; C12Q1/6886
Abstract:
The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients having glioblastomas who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
Public/Granted literature
- US20170051360A1 DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA Public/Granted day:2017-02-23
Information query
